110 related articles for article (PubMed ID: 11209013)
1. Desmopressin may be hazardous in thrombotic microangiopathy.
Stratton J; Warwicker P; Watkins S; Farrington K
Nephrol Dial Transplant; 2001 Jan; 16(1):161-2. PubMed ID: 11209013
[No Abstract] [Full Text] [Related]
2. Percutaneous coronary intervention with stenting in a patient with haemophilia A and an acute myocardial infarction following a single dose of desmopressin.
Virtanen R; Kauppila M; Itälä M
Thromb Haemost; 2004 Nov; 92(5):1154-6. PubMed ID: 15543347
[No Abstract] [Full Text] [Related]
3. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents.
Murgo AJ
Semin Hematol; 1987 Jul; 24(3):161-77. PubMed ID: 3310241
[No Abstract] [Full Text] [Related]
4. Desmopressin-related myocardial infarction in a patient with Wegener's granulomatosis: a case report and review of the literature.
Pape E; Béné J; Buchdahl AL; Gautier S; Hatron PY; Lambert M
J Mal Vasc; 2013 Feb; 38(1):43-6. PubMed ID: 23265678
[TBL] [Abstract][Full Text] [Related]
5. Selection of both normal and bleeding patients is indicated before desmopressin administration.
Girolami A; Vettore S; Fabris F
Thromb Haemost; 2005 Jun; 93(6):1198. PubMed ID: 15968410
[No Abstract] [Full Text] [Related]
6. Transient focal cerebral ischaemia and bilateral pulmonary embolism after desmopressin treatment for von Willebrand's disease.
de Wee EM; Ikram MK; Dippel DW; Leebeek FW
Haemophilia; 2008 Sep; 14(5):1133-4. PubMed ID: 18665851
[No Abstract] [Full Text] [Related]
7. [Bone marrow transplantation related hemolytic uremic syndrome, bone marrow transplantation related thrombotic microangiopathy].
Akiyama H; Sakamaki H; Saito H
Ryoikibetsu Shokogun Shirizu; 1997; (17 Pt 2):542-4. PubMed ID: 9277988
[No Abstract] [Full Text] [Related]
8. Cerebral venous thrombosis associated with thyrotoxicosis, the use of desmopressin and elevated factor VIII/von Willebrand factor.
Waheed W; Aljerdi S; Decker B; Cushman M; Hamill RW
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27503942
[TBL] [Abstract][Full Text] [Related]
9. [Microangiopathic hemolytic anemia in cancers. A case with remission after chemotherapy].
Mariette X; Oberlin F; Brigant S; Koeger AC; Camus JP
Rev Med Interne; 1988; 9(3):297-9. PubMed ID: 3406589
[No Abstract] [Full Text] [Related]
10. Microangiopathic hemolytic anemia and renal impairment following autologous bone marrow transplantation: a case of hemolytic uremic syndrome?
Wassmann B; Martin H; Elsner S; Bruecher J; Thaiss F; Stahl RA; Hoelzer D
Bone Marrow Transplant; 1994 Nov; 14(5):849-51. PubMed ID: 7889019
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin : safety considerations in patients with chronic renal disease.
Sica DA; Gehr TW
Drug Saf; 2006; 29(7):553-6. PubMed ID: 16808548
[No Abstract] [Full Text] [Related]
12. Desmopressin, surgery and thrombosis.
Mannucci PM; Carlsson S; Harris AS
Thromb Haemost; 1994 Jan; 71(1):154-5. PubMed ID: 8165637
[No Abstract] [Full Text] [Related]
13. [Severe hyponatremia and intranasal desmopressin-associated water intoxication in a female patient with diabetes insipidus and histiocytosis X].
Monterrubio Villar J; Córdoba López A; Corcho Sánchez G
Med Clin (Barc); 2003 Apr; 120(15):597. PubMed ID: 12729531
[No Abstract] [Full Text] [Related]
14. Effect on early graft function of high-dose desmopressin in transplant recipients with bleeding disorders.
Tramma D; O'Brien C; Hulton SA
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):364-5. PubMed ID: 23538365
[No Abstract] [Full Text] [Related]
15. Desmopressin and myocardial infarction.
Lowe GD
Lancet; 1989 Apr; 1(8643):895-6. PubMed ID: 2564964
[No Abstract] [Full Text] [Related]
16. Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review.
Nordström B; Strang P
Anticancer Res; 1993; 13(5C):1845-9. PubMed ID: 8267391
[TBL] [Abstract][Full Text] [Related]
17. Severe hyponatraemia after DDAVP stimulation test in an adult patient.
Posthouwer D; Rommes JH; Van Bemmel TJ; Schaar CG
Haemophilia; 2008 Jul; 14(4):844-5. PubMed ID: 18445013
[No Abstract] [Full Text] [Related]
18. Pharmacists have a key role in raising awareness around risks of intranasal desmopressin.
Kwok J; Gue D; Curtis J; Jackson S
J Am Pharm Assoc (2003); 2014; 54(5):460-2. PubMed ID: 25216872
[No Abstract] [Full Text] [Related]
19. Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease.
Bertholini DM; Butler CS
Anaesth Intensive Care; 2000 Apr; 28(2):199-201. PubMed ID: 10788975
[TBL] [Abstract][Full Text] [Related]
20. [Hemolytic-uremic syndrome and microangiopathic hemolytic anemia].
Dacie JV
Recenti Prog Med; 1973 Jan; 54(1):1-22. PubMed ID: 4739645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
